Hypolipidemic and Antioxidant Properties of Oryzanol Concentrate in Reducing Diabetic Nephropathy via SREBP1 Downregulation Rather than β-Oxidation. [electronic resource]
Producer: 20190122Description: e1700511 p. digitalISSN:- 1613-4133
- Animals
- Animals, Outbred Strains
- Antioxidants -- administration & dosage
- Biomarkers -- blood
- Diabetes Mellitus, Experimental -- complications
- Diabetic Nephropathies -- metabolism
- Diet, Carbohydrate Loading -- adverse effects
- Diet, High-Fat -- adverse effects
- Glomerular Filtration Rate
- Hypolipidemic Agents -- administration & dosage
- Kidney -- metabolism
- Lipid Peroxidation
- Male
- Organ Size
- Oxidative Stress
- Phenylpropionates -- administration & dosage
- Protein Multimerization
- Rats, Wistar
- Renal Insufficiency -- complications
- Starch -- adverse effects
- Sterol Regulatory Element Binding Protein 1 -- antagonists & inhibitors
- Transforming Growth Factor beta1 -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.